USPTO serial 79433624
Reviewed by CopyMark Law Group
Status 680 means the examining attorney approved your mark for publication in the USPTO Official Gazette. Publication for opposition usually follows within weeks, opening a 30-day window for third parties to oppose. Watch for publication (status 686) and monitor the 30-day opposition window.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of cancers, asthma, COPD, lupus, rheumatoid arthritis, vasculitis, idiopathic pulmonary fibrosis, lung disease, colitis, organ damage due to sepsis, atherosclerosis and cardiovascular disease; therapeutic antibodies for human use for the treatment of cancers, asthma, COPD, lupus, rheumatoid arthritis, vasculitis, idiopathic pulmonary fibrosis, lung disease, colitis, organ damage due to sepsis, atherosclerosis and cardiovascular disease; therapeutic antibodies for human use for the prevention and treatment of autoimmune diseases; small molecules and synthetic peptides for the prevention and treatment of cancers, asthma, COPD, lupus, rheumatoid arthritis, vasculitis, idiopathic pulmonary fibrosis, lung disease, colitis, organ damage due to sepsis, atherosclerosis and cardiovascular disease | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 1, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 28, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 27, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 27, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 26, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 27, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 27, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 31, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 30, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 29, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 28, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 28, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 23, 2025 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Oct 2, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |